Skip to main content

Table 3 Biomarkers significant for feature F2, ranked by effect size

From: Case-control Indian buffet process identifies biomarkers of response to Codrituzumab

Continuous Variables

Effect Size

p-value

CD3/CD16 necrotic

3.94

1.29e-17

%Necrotic

3.91

9.39e-18

CD3/CD16 viable

−1.27

1.29e-17

%Viable

−1.24

9.39e-18

  1. CD3/CD16 necrotic/viable, staining for CD3 and CD16 in the necrotic tissue and viable cells respectively; %Necrotic/%Viable: percentage of necrotic or viable cells in tissue; AAT: Alanine Aminotransferase. Note that CD3/CD16 necrotic is the count of CD3 CD16 double positive cells in the necrotic tissue and stroma tissue counted together
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us